Literature DB >> 16209608

An efficient synthesis of a dual PPAR alpha/gamma agonist and the formation of a sterically congested alpha-aryloxyisobutyric acid via a Bargellini reaction.

Raymond J Cvetovich1, John Y L Chung, Michael H Kress, Joseph S Amato, Louis Matty, M David Weingarten, Fuh-Rong Tsay, Zhen Li, George Zhou.   

Abstract

A practical synthesis of benzisoxazole 1 and its conversion to alpha-aryloxyisobutyric acid 2 using 1,1,1-trichloro-2-methyl-2-propanol (chloretone) was developed. Benzisoxazole 1 was formed in high yields by the action of either methanesulfonyl chloride/base upon intermediate oxime 8 or with thionyl chloride/base, which initially forms cyclic sulfite 10. A highly reactive, short-lived intermediate derived from chloretone was detected by ReacIR and its half-life determined to be approximately 5 min. Reaction conditions for the Bargellini reaction were developed that resulted in a 95% yield of 2 from the reaction of highly hindered phenol 1 with chloretone hemihydrate and powdered NaOH in acetone. Thus highly hindered alpha-aryloxyisobutyric acids can be made in a single step in high yield.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209608     DOI: 10.1021/jo051027+

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Pivotal Role of an Aliphatic Side Chain in the Development of an HDM2 Inhibitor.

Authors:  Yao Ma; Brian R Lahue; Craig R Gibeau; Gerald W Shipps; Stéphane L Bogen; Yaolin Wang; Zhuyan Guo; Timothy J Guzi
Journal:  ACS Med Chem Lett       Date:  2014-02-24       Impact factor: 4.345

2.  Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model.

Authors:  Ilaria Paterni; Simone Bertini; Carlotta Granchi; Tiziano Tuccinardi; Marco Macchia; Adriano Martinelli; Isabella Caligiuri; Giuseppe Toffoli; Flavio Rizzolio; Kathryn E Carlson; Benita S Katzenellenbogen; John A Katzenellenbogen; Filippo Minutolo
Journal:  J Med Chem       Date:  2015-01-14       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.